Sesquiterpene

Sesquiterpenes are 15-carbon terpene compounds found in plants that exhibit potent anticancer and anti-inflammatory activities through multiple cellular pathways. Artemisinin, the most studied sesquiterpene, demonstrates significant cytotoxicity against cancer cells with IC50 values ranging from 0.93-62.58 μM.

Origin & History

Sesquiterpenes are a class of terpenoids composed of three isoprene units (C15 hydrocarbons), commonly found as secondary metabolites in plants, particularly in the Asteraceae family where they serve as defense mechanisms. Notable sources include Artemisia annua (artemisinin), Tanacetum parthenium (parthenolide), and Thapsia garganica (thapsigargin), with extraction typically involving solvent-based methods followed by chromatographic purification.

Historical & Cultural Context

Sesquiterpene lactones have been used in traditional medicine systems for inflammation and cancer treatment, with artemisinin from Chinese medicine (Artemisia species) and parthenolide from European herbalism (feverfew for migraines and inflammation) being prominent examples. These compounds evolved as plant defense mechanisms against pathogens and herbivores.

Health Benefits

• Anticancer activity: Preclinical studies show IC50 values of 0.93-62.58 μM against various cancer cell lines including HeLa, HepG2, and A549, with compounds like artemisinin reaching clinical trials (preliminary evidence)
• Anti-inflammatory effects: Systematic review indicates potential efficacy for rheumatoid arthritis through cell and cytokine modulation (preliminary evidence)
• Tumor cell selectivity: Sesquiterpene lactones demonstrate selectivity for tumor and cancer stem cells via targeted signaling pathways (preclinical evidence)
• Cell cycle regulation: Compounds induce G2/M phase arrest and apoptosis through multiple pathways including NF-κB/IκBα downregulation (in vitro evidence)
• Oxidative stress modulation: Triggers ROS burst leading to cancer cell death while potentially affecting normal cells at high concentrations (preclinical evidence)

How It Works

Sesquiterpenes like artemisinin induce apoptosis in cancer cells through reactive oxygen species generation and mitochondrial dysfunction. These compounds also modulate inflammatory pathways by inhibiting NF-κB activation and reducing pro-inflammatory cytokine production. Additionally, sesquiterpenes interact with cellular membranes and can disrupt cancer cell proliferation through cell cycle arrest mechanisms.

Scientific Research

While sesquiterpene lactones like artemisinin, thapsigargin, and parthenolide have reached cancer clinical trials, specific RCT details with PMIDs are not provided in the available research. Evidence remains primarily preclinical, consisting of in vitro studies (MTT assays) and mouse xenograft models for NSCLC prodrugs, with one systematic review noting potential for rheumatoid arthritis treatment.

Clinical Summary

Preclinical studies demonstrate sesquiterpenes exhibit cytotoxic effects against HeLa, HepG2, and A549 cancer cell lines with IC50 values of 0.93-62.58 μM. Artemisinin has progressed to clinical trials for cancer treatment, showing preliminary efficacy in early-phase studies. Systematic reviews indicate potential anti-inflammatory benefits, though most evidence remains at the preclinical level. Human clinical data for sesquiterpenes beyond artemisinin remains limited and requires further investigation.

Nutritional Profile

Sesquiterpenes are a class of terpenoid secondary metabolites (C15H24 molecular framework, built from three isoprene units) and are not macronutrients or direct dietary nutrients. They do not contribute measurable calories, protein, fat, or carbohydrates. No vitamin or mineral content is inherent to the class. Key bioactive compounds within this class include: artemisinin (from Artemisia annua, concentration ~0.01-0.8% dry weight of plant material), parthenolide (from feverfew Tanacetum parthenium, ~0.2-0.9% dry weight), beta-caryophyllene (present in black pepper at ~0.5-7 mg/g, cannabis at 3-12 mg/g dry weight, cloves at up to 18 mg/g), farnesol (trace amounts in essential oils and foods), guaiol, and nerolidol. Dietary exposure primarily occurs via consumption of aromatic herbs, spices, and medicinal plants rather than as standalone nutrients. Bioavailability is highly variable: lipophilic nature (logP typically 4-7) facilitates membrane permeability, but first-pass hepatic metabolism significantly reduces oral bioavailability for many compounds (e.g., artemisinin oral bioavailability ~30%; parthenolide <10% estimated). Beta-caryophyllene is orally bioavailable and acts as a dietary cannabinoid via CB2 receptor agonism. Sesquiterpene lactones (e.g., parthenolide, costunolide) contain an alpha-methylene gamma-lactone moiety responsible for biological activity via Michael addition to cellular thiols. No established RDA or dietary reference intake exists for any sesquiterpene subclass.

Preparation & Dosage

No clinically studied dosage ranges for human consumption are specified in the available research. Current data focuses on preclinical IC50 values (0.93-62.58 μM in cell lines) rather than human dosing protocols. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Artemisia annua extract, feverfew, quercetin, green tea polyphenols, curcumin

Safety & Interactions

Sesquiterpenes are generally well-tolerated when consumed through dietary sources, but concentrated supplements may cause gastrointestinal upset in sensitive individuals. Artemisinin can interact with cytochrome P450 enzymes, potentially affecting drug metabolism and warfarin efficacy. High doses may cause dizziness, nausea, and in rare cases, allergic reactions. Pregnant and breastfeeding women should avoid sesquiterpene supplements due to insufficient safety data.